Stay updated on Belantamab Mafodotin in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.

Latest updates to the Belantamab Mafodotin in Myeloma Clinical Trial page
- Check3 days agoChange DetectedThe Version History page now offers a Compare option and displays versioned updates for core sections like Study Status, Recruitment Status, Contacts/Locations, and Study Design, illustrating how the record has changed across versions.SummaryDifference14%

- Check10 days agoChange DetectedThe record history now shows a new site revision entry v3.6.5; the previous revision v3.6.4 entry has been removed.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision entry (v3.6.4) was added to the Study Record Versions, and the previous revision (v3.6.3) was removed, indicating a small system update reflected in the history view.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.3 was added to the Study Record Versions and the previous revision v3.6.2 was removed from the history.SummaryDifference0.1%

- Check54 days agoChange DetectedAn additional revision entry v3.6.2 was added to the study record history, and the previous v3.6.0 entry was removed. This reflects a version update for the page's backend/UI.SummaryDifference0.1%

- Check68 days agoChange DetectedEnrollment is no longer open for the study, indicating recruitment has ended. The history now shows a new version label, v3.6.0, replacing the prior v3.5.5.SummaryDifference0.4%

Stay in the know with updates to Belantamab Mafodotin in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin in Myeloma Clinical Trial page.